• BAP1 Regulation of Disulfidptosis

  2026-09-15

  A 2024 Oncogenesis study identifies BAP1 as a suppressor of glucose starvation-induced disulfidptosis through repression of SLC7A11-dependent cystine uptake and preservation of NADPH-linked reducing capacity. The findings clarify why the same BAP1–SLC7A11 axis can promote ferroptosis in one metabolic context while limiting disulfidptosis in another.

• Saracatinib (AZD0530): From Src Biology to Translation

  2026-09-15

  Saracatinib (AZD0530) offers a mechanistically grounded way to interrogate Src family kinase and Abl signaling across cancer models. This thought-leadership guide connects pathway biology, assay design, xenograft interpretation, and a carefully bounded neuroscience bridge to help translational researchers turn kinase inhibition into more informative experimental decisions.

• I-BET-762: BET Inhibitor Workflow & Applications

  2026-09-14

  I-BET-762 supports both inflammation-focused transcriptional studies and cancer ferroptosis workflows through selective BET bromodomain inhibition. This practical guide connects assay design, solvent handling, ROS/FSP1 readouts, and troubleshooting to published combination data.

• WP1066, JAK2/STAT3 Inhibitor: Assay Guide

  2026-09-14

  This scenario-based guide explains how WP1066, JAK2/STAT3 inhibitor, cell-permeable (SKU A4140), can support reproducible cell viability, proliferation, and pathway-inhibition assays. It connects dose selection, solvent controls, mechanistic readouts, and supplier evaluation with evidence from cancer models and recent JAK2/STAT3 research.

• EdU Flow Cytometry Assay Kits (Cy5): Workflow

  2026-09-13

  EdU Flow Cytometry Assay Kits (Cy5) support flow-cytometric measurement of S-phase DNA synthesis without the harsh DNA-denaturation step used in many BrdU workflows. This guide covers reagent handling, CuAAC detection, controls, and troubleshooting; the assay should be validated separately for systems with restricted EdU incorporation, copper-sensitive downstream steps, or Cy5 spectral conflicts.

• Chloramphenicol and the New Logic of Plasmid AMR

  2026-09-12

  Chloramphenicol is more than a selection antibiotic: its mechanism and workflow utility offer translational researchers a disciplined way to study plasmid maintenance, resistance-gene localization, and horizontal transfer. This article connects molecular biology practice with recent carbapenem-resistant Enterobacter cloacae findings while defining the limits of that cross-domain interpretation.

• TRAP-1 Reactivates p53Y220C Through Induced Proximity

  2026-09-11

  The bioRxiv preprint reports TRAP-1, a small-molecule chemical inducer of proximity that brings mutant p53Y220C into a ternary complex with BRD4. This interaction rapidly increases p21 and other p53 target genes and suppresses growth in p53Y220C-expressing pancreatic cancer cell lines, providing evidence that transcriptional reactivation can be achieved without relying solely on mutant-protein stabilization.

• Angiotensin 1/2 (5-7): RAS Research Guide

  2026-09-11

  Angiotensin 1/2 (5-7) is the H2N-Ile-His-Pro-OH peptide, a short angiotensin fragment supplied for renin-angiotensin system research. Product specifications support controlled biochemical workflows, while a 2025 study provides in vitro evidence that this fragment can enhance SARS-CoV-2 spike–AXL binding.

• Molnupiravir Protects Mice from Bourbon Virus Disease

  2026-09-10

  The reference study demonstrates that molnupiravir can inhibit Bourbon virus replication in cell culture and reduce lethal disease, thrombocytopenia, tissue viral burden, and liver and spleen pathology in mice. Its most important translational insight is that benefit was observed not only with pre-exposure administration but also when treatment began 24 or 48 hours after infection, supporting further evaluation of an orally available antiviral strategy for Bourbon virus.

• Triptolide (PG490) Workflow for Cancer Research

  2026-09-10

  Build reproducible Triptolide workflows around nanomolar transcriptional suppression, invasion assays, immune-cell apoptosis, and cell-cycle-aware imaging. This guide connects PG490’s established RNAPII, IL-2, NF-κB, and matrix-remodeling effects with a new experimental framework for studying transcription condensates and genome stability.

• Cy3 Rabbit Anti-Goat IgG (H+L) Antibody Guide

  2026-09-09

  Cy3 Rabbit Anti-Goat IgG (H+L) Antibody provides fluorescent detection of goat IgG used as a primary or assay-linked immunoglobulin in ICC/IF, IHC, flow cytometry, and ELISA workflows. It should not be used for direct antigen detection or with non-goat primary antibodies unless cross-reactivity has been specifically validated.

• Trichostatin A: HDAC Workflows and Optimization

  2026-09-09

  Trichostatin A (TSA) gives researchers a reversible way to probe HDAC-dependent chromatin, differentiation, cell-cycle, and cytoskeletal biology. This practical guide connects cancer assays with a recent HDAC6–tubulin lactylation discovery while emphasizing controls, exposure design, and troubleshooting.

• Nifedipine (BAY-a-1040) Assay Workflows

  2026-09-08

  Nifedipine (BAY-a-1040) provides a controlled way to test how L-type calcium influx shapes cell signaling, contraction, viability, and transport. Its greatest experimental value emerges when calcium perturbation is paired with orthogonal PXR and CYP measurements rather than interpreted as a direct liver-metabolism signal.

• MLN8237: A Mechanistic Mitosis Assay Guide

  2026-09-08

  MLN8237 (Alisertib) is more than a selective Aurora A inhibitor: it can serve as a mechanistic probe for connecting mitotic disruption, aneuploidy, and apoptosis. This guide integrates product pharmacology with a flow-cytometric assay framework to improve experimental design and interpretation.

• NSC 87877: A Practical Shp2 Inhibitor Guide

  2026-09-07

  This scenario-based guide explains how NSC 87877, SKU A4544, can be used to design more interpretable Shp2 signaling, cell viability, proliferation, and cytotoxicity experiments. It covers assay compatibility, concentration selection, formulation controls, evidence translation, and practical product-selection criteria.

8016 records 1/535 page Next 12345 下5页 Last page